Exercise and Diet Effects on Brain Response in Schizophrenia

This study is exploring how exercise and diet might affect appetite and the brain's response to food in people with schizophrenia. Researchers are also looking at how common medications like olanzapine, risperidone, clozapine, or haloperidol might contribute to weight gain. You could be eligible if you are 21-70 years old, have schizophrenia or schizoaffective disorder, and are either taking one of these medications or no neuroleptic (antipsychotic) medications. The study will measure how your brain responds to food images and ask about your food preferences and symptoms. The goal is to see if exercise or diet changes these brain responses after 14 weeks.

Study design
This is an interventional study planning to enroll 140 participants. It will evaluate the effects of exercise and diet.
What's involved
You would have your brain's response to visual food cues and resting-state brain activity measured. You may also be asked to complete an exercise or diet intervention.
Compensation
Not stated in the trial record.
Follow-up
Your neuronal responses will be measured at 14 weeks.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT02455193

Neuronal Effects of Exercise in Schizophrenia

Recruiting
NAAges 21–70Interventional
University of Colorado, Denver
~140 participants
Updated 2025-04-22 on ClinicalTrials.gov
What's tested:ExerciseDiet

At a glance

Recruiting sites
1 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Neuronal response to visual food cues
Measured over 14 weeks
+1 more outcome measured
Schizophrenia
1 sites across 1 states
Colorado1
  • Jason Tregellas, Ph.D. · PRINCIPAL_INVESTIGATOR · University of Colorado, Denver

Opens a ready-to-send draft in your own email app — review before sending.

Do you actually qualify for this trial?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

Diagnosis of schizophrenia or schizoaffective disorder
Between 21 and 70 years of age
Currently prescribed either olanzapine, risperidone, clozapine, or haloperidol, OR not currently being treated with any neuroleptic medications
Weight stable within 5 percent for the last 6 months

Exclusion

Pregnancy
Substance abuse
Significant endocrine/metabolic disease (e.g., uncontrolled hypertension, severe hypertriglyceridemia)
  • Neuronal response to visual food cues14 weeks

    Neuronal response (insula) while viewing visual food cues

  • Resting-state neuronal response14 weeks

    Neuronal response (default mode network) during rest